Decreased density of benzodiazepine receptors in lymphocytes of anxious patients: reversal after chronic diazepam treatment

Peripheral‐type benzodiazepine receptors were measured in human circulating lymphocytes using 3H‐PK 11195 as specific ligand. In a group of outpatients with anxiety disorders a significant decrease of receptor density (– 37%) was found compared with age‐matched controls. In these patients long‐term diazepam treatment restored binding density to normal levels: the effect persisted after drug withdrawal. Acute i.v. diazepam administration did not change receptor density. The observed receptor changes could reflect a down‐regulation phenomenon and indicate that lymphocyte function reflect central nervous events.

[1]  J. Bidart,et al.  Characterization of a peripheral-type benzodiazepine binding site on human circulating lymphocytes. , 1983, European journal of pharmacology.

[2]  C. Pert,et al.  Benzodiazepine receptor-mediated chemotaxis of human monocytes. , 1985, Science.

[3]  S. Paul,et al.  Endogenous inhibitors of 4'‐[3H]chlorodiazepam (Ro 5‐4864) binding to ‘peripheral’ sites for benzodiazepines , 1984, FEBS letters.

[4]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[5]  D. Greenblatt,et al.  Current Status of Benzodiazepines , 1983 .

[6]  J. Sweeney,et al.  Beta adrenergic receptors and cyclic AMP levels in intact human lymphocytes: effects of age and gender. , 1984, Life sciences.

[7]  S. Paul,et al.  “Peripheral” benzodiazepine binding sites in the maudsley reactive rat: Selective decrease confined to peripheral tissues , 1987, Brain Research Bulletin.

[8]  J. Morley,et al.  Neuropeptides: conductors of the immune orchestra. , 1987, Life sciences.

[9]  B. Bondy,et al.  Binding of 3H-spiperone to human lymphocytes: A biological marker in schizophrenia? , 1985, Psychiatry Research.

[10]  R. Harris,et al.  Rapid preparation of lymphocytes for tissue-typing. , 1969, Lancet.

[11]  E. Costa,et al.  Mitochondrial benzodiazepine receptors regulate steroid biosynthesis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[12]  T. Insel,et al.  A benzodiazepine receptor-mediated model of anxiety. Studies in nonhuman primates and clinical implications. , 1984, Archives of general psychiatry.

[13]  D. Morgan,et al.  The changing drug scene: 1970-1972. , 1974, The American journal of psychiatry.

[14]  R Ader,et al.  Behaviorally Conditioned Immunosuppression , 1974, Psychosomatic medicine.

[15]  S. Paul,et al.  Inescapable shock reduces [3H]Ro 5-4864 binding to “peripheral-type” benzodiazepine receptors in the rat , 1986, Pharmacology Biochemistry and Behavior.

[16]  L. Kiloh,et al.  DEPRESSED LYMPHOCYTE FUNCTION AFTER BEREAVEMENT , 1977, The Lancet.

[17]  S. Dager,et al.  Relapse and rebound following discontinuation of benzodiazepine treatment of panic attacks: alprazolam versus diazepam. , 1989, The American journal of psychiatry.

[18]  J. Rabey,et al.  Cholinergic muscarinic binding by human lymphocytes: Changes with aging, antagonist treatment, and senile dementia of the Alzheimer type , 1986, Annals of neurology.

[19]  C. Pert,et al.  Opiate receptor-mediated chemotaxis of human monocytes , 1985, Neuropeptides.

[20]  J. Greden,et al.  Anxiety or caffeinism: a diagnostic dilemma. , 1974, The American journal of psychiatry.

[21]  D. Hadzi-Pavlovic,et al.  Views of practicing psychiatrists on the treatment of anxiety and somatoform disorders. , 1987, American Journal of Psychiatry.

[22]  D. Charney,et al.  The effects of caffeine on plasma MHPG, subjective anxiety, autonomic symptoms and blood pressure in healthy humans. , 1984, Life sciences.

[23]  A. Guidotti,et al.  Molecular Mechanisms Mediating the Action of Diazepam on GABA Receptors , 1978, British Journal of Psychiatry.

[24]  M. Hamilton.  The assessment of anxiety states by rating. , 1959, The British journal of medical psychology.

[25]  K. Davis,et al.  Lymphocyte function in major depressive disorder. , 1984, Archives of general psychiatry.

[26]  B. Carroll,et al.  Impaired lymphocyte function in depressive illness. , 1983, Life sciences.

[27]  A. Guidotti,et al.  Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Popkin,et al.  Organic anxiety syndrome. , 1983, The American journal of psychiatry.

[29]  A. Cheung,et al.  Inhibitors of peripheral-type benzodiazepine receptors present in human urine and plasma ultrafiltrates. , 1983, Life sciences.

[30]  E. Goetzl,et al.  Modulation of lymphocyte function by sensory neuropeptides. , 1985, Journal of immunology.

[31]  M. Gavish,et al.  Peripheral benzodiazepine binding sites on platelet membranes are increased during diazepam treatment of anxious patients. , 1987, European journal of pharmacology.

[32]  I. Appollonio,et al.  Characterization of peripheral benzodiazepine receptors in human blood mononuclear cells , 1990, Neuropharmacology.

[33]  G. Le Fur,et al.  Opposite effects of two ligands for peripheral type benzodiazepine binding sites, PK 11195 and RO5-4864, in a conflict situation in the rat. , 1985, Life sciences.

[34]  J. Morgan,et al.  Benzodiazepines that bind at peripheral sites inhibit cell proliferation. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[35]  T D Lee,et al.  Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[36]  S. Yamada,et al.  High affinity [3H]flunitrazepam binding: characterization, localization, and alteration in hypertension. , 1981, Life sciences.